Where does MGEN stock trade?

Miragen Therapeutics, Inc. (MGEN) is listed on NASDAQ.

What sector and industry is MGEN in?

Miragen Therapeutics, Inc. operates in the Health Care sector, Medical Specialities industry.

When did Miragen Therapeutics, Inc. go public?

Miragen Therapeutics, Inc. (MGEN) completed its IPO in 2014.

What companies are similar to MGEN?

Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare MGEN side-by-side with any of them on Quantisnow.

How can I track MGEN on Quantisnow?

Quantisnow aggregates Miragen Therapeutics, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MGEN to receive live email and push alerts on every new disclosure.

MGEN

NASDAQ

Miragen Therapeutics, Inc.

SectorHealth CareIndustryMedical SpecialitiesIPO2014

News25/Ratings0

Latest news

25 items

1911d13D/G
SEC Form SC 13G/A filed by Miragen Therapeutics, Inc.
SC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1916d13D/G
SEC Form SC 13G filed
SC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1935d13D/G
SEC Form SC 13G filed
SC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1938d13D/G
SEC Form SC 13G/A filed
SC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1938d13D/G
SEC Form SC 13G/A filed
SC 13G/A - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1946dINSIDER
SEC Form 4 filed by L Joseph Turner
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1946dINSIDER
SEC Form 4 filed by Evan Peter Harwin
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1946dINSIDER
SEC Form 4 filed by S. Jeffrey Hatfield
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1946dINSIDER
SEC Form 4 filed by Tomas Kiselak
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1946dINSIDER
SEC Form 4 filed by Arlene Morris
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1964dINSIDER
SEC Form 3 filed by Barrett Katz
3 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1964dINSIDER
SEC Form 4 filed by Barrett Katz
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1965dINSIDER
SEC Form 4 filed by A. Jason Leverone
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1965dINSIDER
SEC Form 4 filed by Jonathan Violin
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1965dSEC
SEC Form 8-K filed
8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
1966dINSIDER
SEC Form 4 filed by Diana Escolar
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1966dINSIDER
SEC Form 4 filed by M. Lee Rauch
4 - Viridian Therapeutics, Inc.\DE (0001590750) (Issuer)
1966dSEC
SEC Form SC 13G filed
SC 13G - Viridian Therapeutics, Inc.\DE (0001590750) (Subject)
1966dPR
miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
Jonathan Violin, Ph.D., M.B.A. appointed President, CEO and director Barrett Katz, M.D., M.B.A. joins Viridian as Chief Medical OfficerViridian is developing VRDN-001 and VRDN-002 for the treatment of thyroid eye diseaseCompany recently licensed exclusive rights from Xencor, Inc. to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend™ Fc half-life extension technology BOULDER, Colo., Jan. 19, 2021 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a development-stage biotechnology company, today announced its name change to Viridian Therapeutics, Inc. (“Viridian”). Beginning tomorrow, Viridian will trade on NASDAQ under the ticker symbol "VR
1970dSEC
SEC Form 4 filed by Stuart William Marshall
4 - MIRAGEN THERAPEUTICS, INC. (0001590750) (Issuer)
1974dSEC
SEC Form SC 13G filed
SC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
1974dSEC
SEC Form SC 13G filed
SC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
1978dSEC
SEC Form SC 13G filed
SC 13G - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
1980dSEC
SEC Form SC 13D filed
SC 13D - MIRAGEN THERAPEUTICS, INC. (0001590750) (Subject)
1981dSEC
SEC Form 8-K filed
8-K - MIRAGEN THERAPEUTICS, INC. (0001590750) (Filer)

MGEN FAQ

5 questions

Where does MGEN stock trade?
Miragen Therapeutics, Inc. (MGEN) is listed on NASDAQ.
What sector and industry is MGEN in?
Miragen Therapeutics, Inc. operates in the Health Care sector, Medical Specialities industry.
When did Miragen Therapeutics, Inc. go public?
Miragen Therapeutics, Inc. (MGEN) completed its IPO in 2014.
What companies are similar to MGEN?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare MGEN side-by-side with any of them on Quantisnow.
How can I track MGEN on Quantisnow?
Quantisnow aggregates Miragen Therapeutics, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MGEN to receive live email and push alerts on every new disclosure.